ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Director, Quality Control Operations at Vaxcyte - ApplyBlast

Director, Quality Control Operations

Vaxcyte

3 days ago

3.9 on Glassdoor

Visp, Valais, Switzerland

Hybrid

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Director of Quality Control Operations leads the QC Operations team, ensuring day-to-day quality control execution across Vaxcyte's contract manufacturing and testing network. This role oversees the implementation of analytical control strategies, manages vendor collaborations, and ensures timely, compliant batch releases for Vaxcyte products. The position requires strong leadership in quality events, documentation, and audit support while driving a culture of accountability and continuous improvement.

Responsibilities

Lead QC operations and ensure timely batch release across contract networks
Oversee vendor performance and manage contract laboratory relationships
Drive quality investigations and ensure regulatory compliance and inspection readiness

Skills

Qualifications

Bachelor of Science

About Vaxcyte

vaxcyte.com

Headquarters

San Carlos, California, United States

Company Size

51-200 employees

Founded

2013

View Profile

Vaxcyte is a clinical-stage vaccine innovation company dedicated to eliminating bacterial infections — including invasive pneumococcal disease, Group A Strep, and Shigella — using advanced chemistry and a proprietary cell-free protein synthesis platform. Its lead programs, VAX-31 (a 31-valent PCV) and VAX-24 (a 24-valent PCV), are being evaluated in Phase 3 trials for the prevention of invasive pneumococcal disease, with additional early-stage candidates targeting Group A Strep and Shigella. Vaxcyte is also investing up to $1 billion in U.S. biomanufacturing expansion to support scalable vaccine production.